Alterations in plasma hyaluronic acid in patients with clinically stable COPD versus (non)smoking controls
Abstract Hyaluronic acid (HA) is a key component of the extracellular matrix. HA and its metabolism are suggested to be altered in the lungs of patients with chronic obstructive pulmonary disease (COPD). The present study explored systemic HA, and its metabolic regulators, in patients with clinicall...
Guardado en:
Autores principales: | Kiki Waeijen-Smit, Niki L. Reynaert, Rosanne J. H. C. G. Beijers, Sarah Houben-Wilke, Sami O. Simons, Martijn A. Spruit, Frits M. E. Franssen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/68d5b36613634f9f9ad5b73c168b0ad3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of body mass index on task-related oxygen uptake and dyspnea during activities of daily life in COPD.
por: Anouk W Vaes, et al.
Publicado: (2012) -
Redox Dysregulation in Aging and COPD: Role of NOX Enzymes and Implications for Antioxidant Strategies
por: Caspar Schiffers, et al.
Publicado: (2021) -
Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis.
por: Isaac K Sundar, et al.
Publicado: (2014) -
Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons
por: Munuswamy R, et al.
Publicado: (2021) -
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
por: Donato Lacedonia, et al.
Publicado: (2021)